Global Patent Index - EP 1846105 A2

EP 1846105 A2 2007-10-24 - USE OF ADRENERGIC ALPHA2B ANTAGONISTS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS

Title (en)

USE OF ADRENERGIC ALPHA2B ANTAGONISTS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS

Title (de)

VERWENDUNG VON ADRENERGEN ALPHA-2B-ANTAGONISTEN ZUR BEHANDLUNG VON VASOMOTORISCHEN SYMPTOMEN

Title (fr)

UTILISATION D'ANTAGONISTES ALPHA-2B POUR LE TRAITEMENT DE SYMPTOMES VASOMOTEURS

Publication

EP 1846105 A2 (EN)

Application

EP 04794977 A

Priority

  • US 2004033754 W
  • US 51089703 P
  • US 68581203 A
  • US 0332759 W
  • US 96289704 A

Abstract (en)

[origin: WO2005037260A2] The present invention relates to selective adrenergica2B antagonists alone, selective adrenergicalpha2B antagonists in combination with norepinephrine reuptake inhibitors (NRI) (as a single compound or as a combination of two or more compounds), or selective adrenergicalpha2B antagonists in combination with dual norepinephrine reuptake inhibitors/serotonin reuptake inhibitors (NRI/SRI) (as a single compound or as a combination of two or more compounds) and methods of their use in the treatment of vasomotor symptoms.

IPC 8 full level (invention and additional information)

A61P 5/00 (2006.01); A61K 31/00 (2006.01); A61K 31/13 (2006.01); A61K 31/137 (2006.01); A61K 31/138 (2006.01); A61K 31/155 (2006.01); A61K 31/167 (2006.01); A61K 31/381 (2006.01); A61K 31/4174 (2006.01); A61K 31/4178 (2006.01); A61K 31/495 (2006.01); A61K 31/496 (2006.01); A61K 31/497 (2006.01); A61K 31/5377 (2006.01); A61K 31/55 (2006.01); A61K 45/06 (2006.01)

CPC (invention and additional information)

A61K 31/4178 (2013.01); A61K 31/00 (2013.01); A61K 31/13 (2013.01); A61K 31/137 (2013.01); A61K 31/138 (2013.01); A61K 31/155 (2013.01); A61K 31/167 (2013.01); A61K 31/381 (2013.01); A61K 31/4174 (2013.01); A61K 31/495 (2013.01); A61K 31/496 (2013.01); A61K 31/497 (2013.01); A61K 31/5377 (2013.01); A61K 31/55 (2013.01); A61K 45/06 (2013.01)

Combination set (CPC)

  1. A61K 31/13 + A61K 2300/00
  2. A61K 31/137 + A61K 2300/00
  3. A61K 31/138 + A61K 2300/00
  4. A61K 31/167 + A61K 2300/00
  5. A61K 31/4174 + A61K 2300/00
  6. A61K 31/4178 + A61K 2300/00
  7. A61K 31/495 + A61K 2300/00
  8. A61K 31/496 + A61K 2300/00
  9. A61K 31/497 + A61K 2300/00
  10. A61K 31/5377 + A61K 2300/00
  11. A61K 31/55 + A61K 2300/00

Citation (search report)

See references of WO 2005037260A3

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

Designated extension state (EPC)

AL HR LT LV MK

EPO simple patent family

WO 2005037260 A2 20050428; WO 2005037260 A3 20070816; AU 2004281750 A1 20050428; EP 1846105 A2 20071024; MX PA06003866 A 20060703

INPADOC legal status


2009-09-02 [18W] WITHDRAWN

- Effective date: 20090727

2008-02-27 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20080124

2007-10-24 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20060331

2007-10-24 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A2

- Designated State(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

2007-10-24 [AX] REQUEST FOR EXTENSION OF THE EUROPEAN PATENT TO

- Countries: AL HR LT LV MK